Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Academic Licensing Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: PRS063
MIFTS: 37

Paresthesia

Genes Variations Tissues Related diseases Publications Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Paresthesia

About this section

MalaCards integrated aliases for Paresthesia:

Name: Paresthesia 54 29 6 73

External Ids:

UMLS 73 C0030554
Sources

Summaries for Paresthesia

About this section
NINDS : 54 Paresthesia refers to a burning or prickling sensation that is usually felt in the hands, arms, legs, or feet, but can also occur in other parts of the body. The sensation, which happens without warning, is usually painless and described as tingling or numbness, skin crawling, or itching. Most people have experienced temporary paresthesia -- a feeling of "pins and needles" -- at some time in their lives when they have sat with legs crossed for too long, or fallen asleep with an arm crooked under their head. It happens when sustained pressure is placed on a nerve. The feeling quickly goes away once the pressure is relieved. Chronic paresthesia is often a symptom of an underlying neurological disease or traumatic nerve damage. Paresthesia can be caused by disorders affecting the central nervous system, such as stroke and transient ischemic attacks (mini-strokes), multiple sclerosis, transverse myelitis, and encephalitis. A tumor or vascular lesion pressed up against the brain or spinal cord can also cause paresthesia. Nerve entrapment syndromes, such as carpal tunnel syndrome, can damage peripheral nerves and cause paresthesia accompanied by pain. Diagnostic evaluation is based on determining the underlying condition causing the paresthetic sensations. An individual's medical history, physical examination, and laboratory tests are essential for the diagnosis. Physicians may order additional tests depending on the suspected cause of the paresthesia.

MalaCards based summary : Paresthesia is related to facial diplegia with paresthesias and multiple sclerosis, and has symptoms including skin sensation disturbance, hyperalgesia and hyperesthesia. An important gene associated with Paresthesia is FKRP (Fukutin Related Protein). The drugs Lidocaine and Menthol have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, brain and skin.

Wikipedia : 76 Paresthesia is an abnormal sensation such as tingling, tickling, pricking, numbness or burning of a... more...

Sources

Related Diseases for Paresthesia

About this section

Diseases related to Paresthesia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 73)
# Related Disease Score Top Affiliating Genes
1 facial diplegia with paresthesias 12.2
2 multiple sclerosis 11.2
3 carpal tunnel syndrome 11.1
4 fibromyalgia 11.1
5 hypocalcemia, autosomal dominant 1 11.0
6 notalgia paresthetica 10.9
7 thoracic outlet syndrome 10.9
8 hypocalcemia, autosomal dominant 2 10.8
9 brachyolmia type 3 10.8
10 herpes zoster 10.8
11 whiplash 10.8
12 neurofibromatosis, familial spinal 10.8
13 neuritis 10.8
14 neuropathy, hereditary sensory and autonomic, type ia 10.8
15 spondylosis 10.8
16 mitochondrial neurogastrointestinal encephalopathy disease 10.8
17 pernicious anemia 10.8
18 adult-onset nemaline myopathy 10.8
19 cramp-fasciculation syndrome 10.8
20 pruritus, hereditary localized 10.8
21 lipedematous scalp 10.8
22 tabes dorsalis 10.8
23 multiple sclerosis 3 10.8
24 multiple sclerosis 5 10.8
25 radial neuropathy 10.8
26 burns 10.0
27 cervicitis 10.0
28 back pain 9.9
29 dermatitis 9.9
30 depression 9.9
31 cerebritis 9.9
32 cerebral amyloid angiopathy, cst3-related 9.8
33 chronic pain 9.8
34 breast cancer 9.8
35 neuronitis 9.8
36 periodontitis 9.8
37 herpes simplex 9.8
38 contact dermatitis 9.8
39 allergic contact dermatitis 9.8
40 mononeuropathy of the median nerve, mild 9.8
41 guillain-barre syndrome 9.7
42 polyradiculopathy 9.7
43 polyglucosan body myopathy 1 with or without immunodeficiency 9.7
44 paronychia 9.7
45 cervical adenitis 9.7
46 burn scar 9.7
47 diarrhea 9.7
48 foot drop 9.7
49 polyneuropathy 9.7
50 headache 9.7

Graphical network of the top 20 diseases related to Paresthesia:



Diseases related to Paresthesia
Sources

Symptoms & Phenotypes for Paresthesia

About this section

UMLS symptoms related to Paresthesia:


skin sensation disturbance, hyperalgesia, hyperesthesia, numbness, circumoral paresthesia, paresthesia, distal, paresthesia mucosal, paresthesia skin, tingling mucosal, tingling of skin, back paresthesia, buttock paresthesia, extremity paresthesia, facial paresthesia, facial paresthesia, unilateral, finger paresthesia, lip paresthesia, nose paresthesia, palmar pain, palmar paresthesia, burning sensation of skin, thigh numbness, thigh paresthesia, trunk paresthesia, dysesthesia, abnormal sensation, pins and needles, burning mucosal, paresthesia mouth, electric shock sensation, paresthesia upper limb, stinging sensation, painful paresthesias, paresthesia lower limb, has tingling sensation
Sources

Drugs & Therapeutics for Paresthesia

About this section

Drugs for Paresthesia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 502)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 137-58-6 3676
2
Menthol Approved Phase 4,Not Applicable 2216-51-5 16666
3
Bupivacaine Approved, Investigational Phase 4,Phase 1,Not Applicable 2180-92-9, 38396-39-3 2474
4
Ketorolac Approved Phase 4,Not Applicable 74103-06-3, 66635-83-4 3826
5
Diclofenac Approved, Vet_approved Phase 4,Phase 2,Not Applicable 15307-86-5 3033
6
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 50-02-2 5743
7
Triamcinolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 124-94-7 31307
8
Ropivacaine Approved Phase 4,Phase 3,Phase 2,Not Applicable 84057-95-4 71273 175805
9
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51-43-4 5816
10
Levobupivacaine Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 27262-47-1 92253
11
Racepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 329-65-7 838
12
rituximab Approved Phase 4,Phase 2,Phase 1 174722-31-7 10201696
13
Acetazolamide Approved, Vet_approved Phase 4,Not Applicable 59-66-5 1986
14
Doxycycline Approved, Investigational, Vet_approved Phase 4,Not Applicable 564-25-0 54671203
15
Dopamine Approved Phase 4,Phase 3,Phase 2,Not Applicable 51-61-6, 62-31-7 681
16
Famciclovir Approved, Investigational Phase 4,Phase 3,Not Applicable 104227-87-4 3324
17
Ephedrine Approved Phase 4,Phase 3 299-42-3 9294
18
Penciclovir Approved Phase 4 39809-25-1 4725
19
Pseudoephedrine Approved Phase 4,Phase 3 90-82-4 7028
20
Methotrexate Approved Phase 4 1959-05-2, 59-05-2 126941
21
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 51-41-2 439260
22
Aspirin Approved, Vet_approved Phase 4,Phase 3 50-78-2 2244
23
Desogestrel Approved Phase 4 54024-22-5 40973
24
Phenylephrine Approved Phase 4 59-42-7 6041
25
Gabapentin Approved, Investigational Phase 4,Not Applicable 60142-96-3 3446
26
Morphine Approved, Investigational Phase 4,Phase 3 57-27-2 5288826
27
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 148553-50-8 5486971
28
Metronidazole Approved Phase 4 443-48-1 4173
29
Nitric Oxide Approved Phase 4 10102-43-9 145068 160954
30
Dexmedetomidine Approved, Vet_approved Phase 4 113775-47-6 68602 5311068
31
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
32
Oxycodone Approved, Illicit, Investigational Phase 4,Phase 3,Not Applicable 76-42-6 5284603
33
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 1 50-24-8 5755
34
Oxaliplatin Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 61825-94-3 5310940 9887054 43805 6857599
35
Acetaminophen Approved Phase 4,Phase 2,Not Applicable 103-90-2 1983
36
Cefuroxime Approved Phase 4 55268-75-2 5361202 5479529
37
Ibuprofen Approved Phase 4 15687-27-1 3672
38
Metoprolol Approved, Investigational Phase 4 37350-58-6, 51384-51-1 4171
39
Nebivolol Approved, Investigational Phase 4 152520-56-4, 99200-09-6, 118457-14-0 71301
40
Oxymetazoline Approved, Investigational Phase 4 1491-59-4 4636
41
Benzocaine Approved, Investigational Phase 4,Not Applicable 1994-09-7, 94-09-7 2337
42
Mepivacaine Approved, Vet_approved Phase 4,Not Applicable 96-88-8 4062
43
Dimethyl fumarate Approved, Investigational Phase 4,Phase 3 624-49-7 5271565 637568
44
Acyclovir Approved Phase 4,Phase 3 59277-89-3 2022
45
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Not Applicable 437-38-7 3345
46
Angiotensin II Approved, Investigational Phase 4,Phase 2 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
47
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 1 83-43-2 6741
48
Etonogestrel Approved, Investigational Phase 4 54048-10-1 40976 6917715
49
Fluorouracil Approved Phase 4,Phase 3,Phase 2,Phase 1 51-21-8 3385
50
Nitrous oxide Approved, Vet_approved Phase 4,Phase 2 10024-97-2 948

Interventional clinical trials:

(show top 50) (show all 616)
# Name Status NCT ID Phase Drugs
1 Spinal Cord Stimulation (SCS) in Refractory Angina Unknown status NCT00121654 Phase 4
2 The Role of Levothyroxine on Goiter With Atypia of Undetermined Significance Unknown status NCT02329379 Phase 4 Levothyroxine
3 Ultrasound Guided Pectoral Nerve I and II Blocks in Multimodal Analgesia for Breast Surgery Unknown status NCT02672813 Phase 4
4 Efficacy of Gabapentin in the Treatment of Chest Pain and Paresthesia in Patients With Sternotomy Completed NCT00800527 Phase 4 Gabapentin;Diclofenac
5 Safety of Two Epidural Catheters in Thoracic Epidural Anaesthesia (TEA) Completed NCT00394459 Phase 4
6 Optimized Programming in Spinal Cord Stimulation (SCS) System Completed NCT00871819 Phase 4
7 Safety of Orectalip® (Oxaliplatin) as Adjuvant Treatment for High-risk Stage-â…¡ Colorectal Cancer Completed NCT02284529 Phase 4 Orectalip
8 Changes in Cerebral Blood Flow in Patients Treated With Spinal Cord Stimulation for Low Back and Leg Pain Completed NCT00418301 Phase 4
9 Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing Completed NCT01993667 Phase 4 Acetazolamide
10 Postoperative Alpha Lipoic Acid in the Carpal Tunnel Syndrome: a Randomized Controlled Trial. Completed NCT01895621 Phase 4
11 Alpha Lipoic Acid for Treatment of Diabetic Neuropathy Completed NCT02439879 Phase 4 Alpha lipoic acid
12 Addition of Dexmedetomidine to Ropivacaine-induced Supraclavicular Block (ADRIB Trial) Completed NCT02630290 Phase 4 Ropivacaine;Ropivacaine + Dexmedetomidine
13 Ophthalmic Findings During 10-year Enzyme Substitution of Danish Fabry Patients. Completed NCT01997489 Phase 4 Enzyme replacement
14 Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Venous Insufficiency Completed NCT00835822 Phase 4 Venocur Triplex®;placebo
15 Efficacy Study of the Octapolar Lead in Patients With Failed Back Surgery Syndrome (FBSS) With Chronic Pain Completed NCT01096147 Phase 4
16 A Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers Completed NCT00820534 Phase 4 Penciclovir;Placebo
17 Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) Completed NCT00913081 Phase 4
18 Ibuprofen vs Acetaminophen for AMS Prevention Completed NCT02244437 Phase 4 Ibuprofen;Acetaminophen
19 Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder Completed NCT00903045 Phase 4 Propiverine hydrochloride;Placebo
20 Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis Completed NCT01593332 Phase 4 Rituximab;Rituximab
21 β-alanine Supplementation on Knee Extensor Contractile and Force Properties Completed NCT02819505 Phase 4
22 Efficacy Study of Local Steroid Injection and Wrist Splinting for Carpal Tunnel Syndrome Completed NCT02140632 Phase 4
23 Bispectral Index and Clinical Parameters Evaluation in Dental Procedures Completed NCT02671578 Phase 4 Nitrous Oxide
24 Early Versus Standard Postpartum Insertion of the Etonogestrel Contraceptive Implant Completed NCT00847587 Phase 4 Etonogestrel contraceptive implant;Etonogestrel contraceptive implant
25 Perineural Steroids for Peripheral Nerve Blocks Completed NCT02462148 Phase 4 Dexamethasone;Bupivacaine;Epinephrine
26 Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD) Completed NCT01056289 Phase 4 Desvenlafaxine Succinate Sustained-Release Formulation 50 mg;Desvenlafaxine Succinate Sustained-Release Formulation 25 mg;Placebo
27 Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006) Completed NCT02256553 Phase 4 Rescue Medication
28 Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis Completed NCT02090413 Phase 4 dimethyl fumarate;acetylsalicylic acid;ASA-Placebo
29 Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological Outcome Completed NCT01518192 Phase 4 doxycycline;cefuroxime axetil
30 Efficacy of Interscalene Brachial Plexus Block With Liposomal Bupivacaine for Arthroscopic Shoulder Surgery Completed NCT01977352 Phase 4 Liposomal bupivacaine;Bupivacaine 0.25%
31 Efficacy and Safety of Coumarin and Troxerutin in the Symptomatic Treatment of Chronic Venous Insufficiency Completed NCT01848210 Phase 4 Coumarin/troxerutin;Placebo
32 Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea Completed NCT03380390 Phase 4 Oxymetazoline HCL 1.0% Cream
33 Ultrasound Guidance for Interscalene Brachial Plexus Block Completed NCT00702416 Phase 4 Ropivacaine;Paracetamol;Morphine;Fentanyl
34 Ultrasound Plus Nerve Stimulator Versus Nerve Stimulator Guided Lumbar Plexus Block Completed NCT02020096 Phase 4
35 Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and Pregabalin Completed NCT01352741 Phase 4 Tapentadol Prolonged Release;Tapentadol Prolonged Release with Pregabalin;Tapentadol Prolonged Release open label maintenance
36 Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component. Completed NCT01838616 Phase 4 Tapentadol Prolonged Release;Oxycodone/Naloxone Prolonged Release
37 The Retroclavicular Approach for Regional Anesthesia of the Upper Limb in Obese Patients Completed NCT02086643 Phase 4
38 Tissue Glue (Cyanoacrylate) Versus Conventional Suture in Kidney Donors Completed NCT01521871 Phase 4
39 Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients Completed NCT00477334 Phase 4 Famciclovir;Placebo
40 A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP) Completed NCT02417935 Phase 4 Duloxetine;Pregabalin;Placebo
41 Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients Completed NCT01502787 Phase 4 Metoprolol succinate;Nebivolol;Angiotensin II
42 The Retroclavicular Approach for Regional Anesthesia Completed NCT01852396 Phase 4
43 Efficacy and Safety of Gabapentin/B-complex Versus Pregabalin in Diabetic Peripheral Neuropathy Pain Management Completed NCT01364298 Phase 4 Gabapentin/B-complex;Pregabalin
44 Effect of Dexamethasone Dose and Route on Duration of Interscalene Block After Outpatient Shoulder Surgery Completed NCT02426736 Phase 4 Dexamethasone;Bupivacaine
45 Efficacy Of Pregabalin In Subjects With Post-Stroke Central Neuropathic Pain Completed NCT00313820 Phase 4 Pregabalin;Placebo
46 Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease Recruiting NCT03063190 Phase 4 Vitamin D;Placebo Oral Tablet
47 Does Saline Injection Around Phrenic Nerve Reduce Incidence of Diaphragmatic Paresis Following Interscalene Block? Recruiting NCT02893228 Phase 4 Levobupivacaine
48 Treatment of Post-dural Puncture Headache in Postpartum Patients: Sphenopalatine Ganglion Block to Epidural Blood Patch. Recruiting NCT02962427 Phase 4 Sphenopalatine ganglion Block
49 Comparison of 1000 Hertz (Hz), Burst, and Standard Spinal Cord Stimulation in Chronic Pain Relief Recruiting NCT02902796 Phase 4
50 Thiamin Deficiency in Obese Thai Children Recruiting NCT02464865 Phase 4 Thiamine 1;Thiamine 2

Search NIH Clinical Center for Paresthesia

Sources

Genetic Tests for Paresthesia

About this section

Genetic tests related to Paresthesia:

# Genetic test Affiliating Genes
1 Paresthesia 29
Sources

Anatomical Context for Paresthesia

About this section

MalaCards organs/tissues related to Paresthesia:

41
Spinal Cord, Brain, Skin, Testes, Kidney, Lung, Bone
Sources

Publications for Paresthesia

About this section

Articles related to Paresthesia:

(show top 50) (show all 312)
# Title Authors Year
1
Sub-paresthesia spinal cord stimulation reverses thermal hyperalgesia and modulates low frequency EEG in a rat model of neuropathic pain. ( 29740068 )
2018
2
Extending Coronectomy Indications to Third Molars with Taurodontism to Prevent Paresthesia and Mandible Fracture. ( 29808127 )
2018
3
The Anatomical Nature of Dental Paresthesia: A Quick Review. ( 29541262 )
2018
4
Spinal Cord Stimulation for Treating Chronic Pain: Reviewing Preclinical and Clinical Data on Paresthesia-Free High-Frequency Therapy. ( 29105244 )
2018
5
Risk factors for hypertrophic burn scar pain, pruritus, and paresthesia development. ( 29719102 )
2018
6
Role of Panoramic Imaging and Cone Beam CT for Assessment of Inferior Alveolar Nerve Exposure and Subsequent Paresthesia Following Removal of Impacted Mandibular Third Molar. ( 29618893 )
2018
7
Low-level laser therapy may reduce the time of recovery from paresthesia after orthognathic surgery. ( 29221612 )
2018
8
Paresthesia frequency in fibromyalgia and its effects on personality traits. ( 29968325 )
2018
9
Influence of Electroacupuncture and Laser-Acupuncture on Treating Paresthesia in Patients Submitted to Combined Orthognathic Surgery and Genioplasty. ( 29067139 )
2017
10
Electroacupuncture Therapy for Auricular Paresthesia. ( 29067145 )
2017
11
Clinical Paresthesia Atlas Illustrates Likelihood of Coverage Based on Spinal Cord Stimulator Electrode Location. ( 28370724 )
2017
12
Clinical Reasoning: A 71-year-old woman with subacute progressive distal weakness and paresthesia after vaccination. ( 28438848 )
2017
13
Does the Surgical Management of the Intercostobrachial Nerve Influence the Postoperatory Paresthesia of the Upper Limb and Life Quality in Breast Cancer Patients? ( 28862120 )
2017
14
Guillain-BarrAc Syndrome: A Variant Consisting of Facial Diplegia and Paresthesia with Left Facial Hemiplegia Associated with Antibodies to Galactocerebroside and Phosphatidic Acid. ( 28966341 )
2017
15
Reversed Palmaris Longus Muscle CausingA Volar Forearm Pain and UlnarA Nerve Paresthesia. ( 27964899 )
2017
16
Paresthesia-Independence: An Assessment of Technical Factors Related to 10 kHz Paresthesia-Free Spinal Cord Stimulation. ( 28535555 )
2017
17
Persistent lingual paresthesia caused by a displaced tooth fragment: a case report and literature review. ( 29354592 )
2017
18
Effect of Acupuncture on Post-implant Paresthesia. ( 28483185 )
2017
19
Comparison between Steroid Injection and Stretching Exercise on the Scalene of Patients with Upper Extremity Paresthesia: Randomized Cross-Over Study. ( 26847305 )
2016
20
Primary somatosensory/motor cortical thickness distinguishes paresthesia-dominant from pain-dominant carpal tunnel syndrome. ( 26761384 )
2016
21
Acetabular Paralabral Cyst: An Unusual Cause of Lower Extremity Pain and Paresthesia. ( 26721454 )
2016
22
Nerve Fiber Activation During Peripheral Nerve Field Stimulation: Importance of Electrode Orientation and Estimation of Area of Paresthesia. ( 26586248 )
2016
23
High-Frequency Stimulation of Dorsal Column Axons: Potential Underlying Mechanism of Paresthesia-Free Neuropathic Pain Relief. ( 27145196 )
2016
24
Odontogenic keratocysts in the Basal Cell Nevus (Gorlin-Goltz) Syndrome associated with paresthesia of the lower jaw: Case report, retrospective analysis of a representative Czech cohort and recommendations for the early diagnosis. ( 27857042 )
2016
25
Reducing Adverse Effects During Drug Development: The Example of Lesogaberan and Paresthesia. ( 26947796 )
2016
26
Exercising Impacts on Fatigue, Depression, and Paresthesia in Female Patients with Multiple Sclerosis. ( 26656775 )
2016
27
Rare case of small size Extraskeletal Ewing Sarcoma arising from the median nerve with paresthesia. ( 27523258 )
2016
28
Evaluation of pulsing magnetic field effects on paresthesia in multiple sclerosis patients, a randomized, double-blind, parallel-group clinical trial. ( 27556294 )
2016
29
Clinical Outcomes of 1 kHz Subperception Spinal Cord Stimulation in Implanted Patients With Failed Paresthesia-Based Stimulation: Results of a Prospective Randomized Controlled Trial. ( 27186822 )
2016
30
Facial Diplegia with Paresthesia: An Uncommon Variant of Guillain-Barre Syndrome. ( 27630886 )
2016
31
Infection Related Inferior Alveolar Nerve Paresthesia in the Lower Premolar Teeth. ( 27597904 )
2016
32
Topiramate-induced paresthesia is more frequently reported by migraine than epileptic patients. ( 26809953 )
2016
33
Home Use of a Pyrethroid-Containing Pesticide and Facial Paresthesia in a Toddler: A Case Report. ( 27548193 )
2016
34
Left Chin Paresthesia in an Elderly Man-An Unusual But Ominous Variety of Neuralgia. ( 27317228 )
2016
35
Paresthesia and sensory disturbances associated with 2009 pandemic vaccine receipt: Clinical features and risk factors. ( 26209839 )
2015
36
Characteristic Findings on Panoramic Radiography and Cone-beam CT to Predict Paresthesia after Extraction of Impacted Third Molar. ( 25765570 )
2015
37
How Can Paresthesia After Zygomaticomaxillary Complex Fracture Be Determined After Long-Term Follow-Up? A New and Quantitative Evaluation Method Using Current Perception Threshold Testing. ( 25865713 )
2015
38
Laser Therapy in the Treatment of Paresthesia: A Retrospective Study of 125 Clinical Cases. ( 26226172 )
2015
39
Endodontic periapical lesion-induced mental nerve paresthesia. ( 25878687 )
2015
40
Recurrent Spontaneous Paresthesia in the Upper Limb Could Be Due to Migraine: A Case Series. ( 26234162 )
2015
41
Paresthesia: A Review of Its Definition, Etiology and Treatments in View of the Traditional Medicine. ( 26561077 )
2015
42
Performance effects of acute I^-alanine induced paresthesia in competitive cyclists. ( 25636080 )
2015
43
Report of Transient Paresthesia Following Transcranial Stimulation. ( 26050601 )
2015
44
Massive mandibular destruction and alveolar nerve infiltration without lower lip paresthesia in primary intraosseous carcinoma: report of two cases and critical appraisal of diagnostic criteria. ( 25485318 )
2015
45
65-year-old woman with intermittent fevers, lower extremity paresthesia, weight loss, and malaise. Glomerulonephritis. ( 25939938 )
2015
46
A 64-year old woman with right hand swelling and paresthesia. ( 26233638 )
2015
47
Temporary Mental Nerve Paresthesia Originating from Periapical Infection. ( 26345692 )
2015
48
Paresthesia-Free High-Density Spinal Cord Stimulation for Postlaminectomy Syndrome in a Prescreened Population: A Prospective Case Series. ( 26481726 )
2015
49
Delayed upper extremity paresthesia post permanent implantation of five lead spinal cord stimulator for low back and lower extremity pain: A case report. ( 25958176 )
2015
50
A rare cause of episodic paresthesia: spinal cavernoma. ( 25937116 )
2015
Sources

Variations for Paresthesia

About this section

ClinVar genetic disease variations for Paresthesia:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 FKRP NM_024301.4(FKRP): c.826C> A (p.Leu276Ile) single nucleotide variant Pathogenic rs28937900 GRCh37 Chromosome 19, 47259533: 47259533
2 FKRP NM_024301.4(FKRP): c.826C> A (p.Leu276Ile) single nucleotide variant Pathogenic rs28937900 GRCh38 Chromosome 19, 46756276: 46756276
3 CAPN3; SGCB NM_000070.2(CAPN3): c.550delA (p.Thr184Argfs) deletion Pathogenic rs80338800 GRCh37 Chromosome 15, 42680002: 42680002
4 CAPN3; SGCB NM_000070.2(CAPN3): c.550delA (p.Thr184Argfs) deletion Pathogenic rs80338800 GRCh38 Chromosome 15, 42387804: 42387804
5 MT-ND6 NC_012920.1: m.14477A> G single nucleotide variant Uncertain significance GRCh37 Chromosome MT, 14477: 14477
6 MT-ND6 NC_012920.1: m.14477A> G single nucleotide variant Uncertain significance GRCh38 Chromosome MT, 14477: 14477
Sources

Expression for Paresthesia

About this section
Search GEO for disease gene expression data for Paresthesia.
Sources

Pathways for Paresthesia

About this section
Sources

GO Terms for Paresthesia

About this section
Sources

Sources for Paresthesia

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....